Compare Erasca Inc. Common Stock (ERAS) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Erasca Inc. Common Stock vs Edwards Lifesciences Corporation Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.63 (market cap $5.40B), while Edwards Lifesciences Corporation Common Stock trades at $83.6 (market cap $48.56B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 9× Erasca Inc. Common Stock's market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| ERAS | EW | |
|---|---|---|
Market Cap | $5.40B | $48.56B |
Volume | 9,533,185 | 6,520,488 |
Sector | Health | Health |
52-Week High | $22.47 | $95.18 |
52-Week Low | $2.20 | $72.65 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $5.18B | $45.01B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Erasca Inc. Common Stock
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
